During the past decade, UNC Center for Functional GI & Motility Disorders conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNC Center for Functional GI & Motility Disorders" #1 sponsor was "University of North Carolina, Chapel Hill" with 2 trials, followed by "Dynogen Pharmaceuticals" with 1 trials sponsored, "Medtronic - MITG" with 1 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials sponsored and "Spencer Dorn, MD, MPH" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Center for Functional GI & Motility Disorders" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator and "Forest Laboratories" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UNC Center for Functional GI & Motility Disorders" are "Irritable Bowel Syndrome" (3 trials), "Abdominal Pain" (1 trials), "Barrett Esophagus" (1 trials), "Constipation" (1 trials) and "Diarrhea Predominant Irritable Bowel Syndrome" (1 trials). Many other conditions were trialed in "UNC Center for Functional GI & Motility Disorders" in a lesser frequency.

Most popular intervention types in "UNC Center for Functional GI & Motility Disorders" are "Drug" (4 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation System plus anti-secretory medication" (1 trials), "Cognitive Behavioral Treatment" (1 trials), "DDP733" (1 trials), "Desipramine" (1 trials) and "Milnacipran" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Center for Functional GI & Motility Disorders" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "UNC Center for Functional GI & Motility Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UNC Center for Functional GI & Motility Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Center for Functional GI & Motility Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".